Attributes | Attribute label used in survey | Attribute supplementary information | Levels | Opt-out option level | References |
---|---|---|---|---|---|
Mortality by prostate cancer | Number of deaths by prostate cancer | 2 / 1000a 5 / 1000a 6 / 1000a | 6 / 1000 | Schröder et al.(2014) [3] | |
False positive result | Number of false positive results to the screening test (false alarm) | This wrong alert induces potentially useless supplementary exams (biopsies) because men do not have cancer | 50 / 1000a 150 / 1000a 250/ 1000a | 0 | Kipeläinen, et al. (2011) [25] |
False negative result | Number of false negative results on screening test | Prostate cancer is undetected yet individual has prostate cancer | 1 / 1000 5 / 1000 10 / 1000 | 0 | Verbeek, et al. (2018) [24] |
Overdiagnosis | Number of prostate cancers detected, even treated unnecessarily (overdiagnosis) | This prostate cancer would never cause symptoms, pain or death | 10 / 1000a 30 / 1000a 50 / 1000a | 0 | Etzioni, et al. (2013) [22] |
Recommended frequency | Frequency at which you should be screened | Every year Every 2 years Every 4 years | NA | Tsodikov et al. (2017) [2] | |
Out-of-pocket costs | Amount to pay for each screening session | Amount is not reimbursed by national health insurance or supplementary health insurance | 0 € 10 € 20 € 40 € | 0 |